Literature DB >> 1973224

Fluoride treatment for osteoporosis.

C Nagant de Deuxchaisnes, J P Devogelaer, F Stein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1973224     DOI： 10.1016/0140-6736(90)91556-p

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Determination of reference concentrations of strontium in urine by inductively coupled plasma atomic emission spectrometry.

Authors:  Kan Usuda; Koichi Kono; Satsuki Hayashi; Takashi Kawasaki; Go Mitsui; Takahiro Shibutani; Emi Dote; Kazuya Adachi; Michiko Fujihara; Yukari Shimbo; Wei Sun; Bo Lu; Kazuo Nakasuji
Journal:  Environ Health Prev Med       Date:  2006-01       Impact factor: 3.674

2.  A mathematical model for fluoride uptake by the skeleton.

Authors:  C H Turner; G Boivin; P J Meunier
Journal:  Calcif Tissue Int       Date:  1993-02       Impact factor: 4.333

3.  Fluoride salts for vertebral osteoporosis: the benefit-to-risk ratio depends on the cumulative dose reaching bone.

Authors:  P J Meunier; G Boivin
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

4.  Comparison of serum fluoride levels after administration of monofluorophosphate-calcium carbonate or sodium fluoride: differences in peak serum concentrations.

Authors:  L Erlacher; H Teufelsbauer; P Bernecker; P Pietschmann; M Weissel
Journal:  Clin Investig       Date:  1994-12

Review 5.  Fluoride therapy of type I osteoporosis.

Authors:  J P Devogelaer; C Nagant de Deuxchaisnes
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

Review 6.  Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 7. Fluoride therapy for osteoporosis.

Authors:  T M Murray; L G Ste-Marie
Journal:  CMAJ       Date:  1996-10-01       Impact factor: 8.262
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.